We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
-6.61%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$266M
AUM Growth
-$131K
(-0.05%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
8.44%
Top 10 Holdings %
Top 10 Hldgs %
48.53%
Holding
96
New
9
Increased
25
Reduced
15
Closed
6
Top Buys
| 1 |
Fate Therapeutics
FATE
|
+$7.86M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$4.67M |
| 3 |
TVRD
Tvardi Therapeutics
TVRD
|
+$4.02M |
| 4 |
Alector
ALEC
|
+$2.2M |
| 5 |
MacroGenics
MGNX
|
+$2.16M |
Top Sells
| 1 |
Quince Therapeutics
QNCX
|
+$2.78M |
| 2 |
Indaptus Therapeutics
INDP
|
+$1.8M |
| 3 |
NextCure
NXTC
|
+$1.44M |
| 4 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
+$1.41M |
| 5 |
argenx
ARGX
|
+$1.32M |
Sector Composition
| 1 | Healthcare | 92.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$161M
| $48M | 18.06% |
13,680,554
| – | – |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $17.5M | 6.58% |
124,806
+1,000
| +0.8% | +$167K |
|
|
ALDR
3
DELISTED
Alder Biopharmaceuticals
ALDR
| $12M | 4.51% |
636,013
| – | – |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $9.05M | 3.4% |
123,218
| – | – |
|
|
LKFT
5
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $8.02M | 3.01% |
52,509
| – | – |
|
6
AtriCure
ATRC
$1.75B
| $7.95M | 2.99% |
318,729
| – | – |
|
|
7
Fate Therapeutics
FATE
$349M
| $7.3M | 2.75% |
470,000
+409,969
| +683% | +$7.86M |
|
|
TVRD
8
Tvardi Therapeutics
TVRD
$27.5M
| $6.93M | 2.61% |
10,526
+4,831
| +85% | +$4.02M |
|
9
iShares Biotechnology ETF
IBB
$9.24B
| $6.46M | 2.43% |
64,900
+3,500
| +6% | +$366K |
|
10
Ascendis Pharma A/S
ASND
$17.6B
| $5.83M | 2.19% |
60,480
+1,100
| +2% | +$123K |
|
11
Neurocrine Biosciences
NBIX
$17.3B
| $5.81M | 2.19% |
64,508
-100
| -0.2% | -$9.34K |
|
|
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
| $5.72M | 2.15% |
142,764
+2,000
| +1% | +$92.2K |
|
|
AERI
13
DELISTED
Aerie Pharmaceuticals
AERI
| $5.53M | 2.08% |
287,748
+82,308
| +40% | +$1.89M |
|
14
DexCom
DXCM
$28.1B
| $5.42M | 2.04% |
145,352
| – | – |
|
15
Cytokinetics
CYTK
$11.2B
| $4.76M | 1.79% |
418,727
-58,469
| -12% | -$734K |
|
|
ARNA
16
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.3M | 1.62% |
93,942
| – | – |
|
|
LMNX
17
DELISTED
Luminex Corp
LMNX
| $4.21M | 1.58% |
204,091
+10,000
| +5% | +$208K |
|
|
APLS
18
DELISTED
Apellis Pharmaceuticals
APLS
| $4.09M | 1.54% |
+169,800
| New | +$4.67M |
|
19
Wave Life Sciences
WVE
$1.14B
| $4.06M | 1.53% |
197,554
-20,000
| -9% | -$459K |
|
|
BHVN
20
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.96M | 1.49% |
95,000
| – | – |
|
21
VYNE Therapeutics
VYNE
$25.3M
| $3.84M | 1.44% |
11,902
+3,568
| +43% | +$1.15M |
|
|
ARQL
22
DELISTED
Arqule Inc
ARQL
| $3.8M | 1.43% |
530,262
+32,500
| +7% | +$305K |
|
|
TBIO
23
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $3.61M | 1.36% |
364,229
+185,923
| +104% | +$1.76M |
|
24
Akebia Therapeutics
AKBA
$370M
| $3.25M | 1.22% |
828,038
-2,500
| -0.3% | -$10.7K |
|
25
Xenon Pharmaceuticals
XENE
$6.55B
| $2.98M | 1.12% |
330,667
| – | – |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML